
Regulation, Enforcement, and Associated Challenges: Part II
Given the continued challenges in policing the burgeoning ENDS marketplace, as previously discussed in Part I of this article, in mid-2024 FDA and DOJ announced the establishment of a federal multi-agency task force to combat the “illegal distribution and …